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T.A.M. Chuter, J.H. Rapp, J.S. Hiramoto, D.B. Schneider, B. Howell and
L.M. Reilly
Objective. This study assessed the role of multibranched stent grafts for thor-
acoabdominal aortic aneurysm (TAAA) repair.
Methods. Self-expanding covered stents were used to connect the caudally
directed cuffs of an aortic stent graft with the visceral branches of a TAAA
in 22 patients (16 men, 6 women) with a mean age of 76  7 years. All patients
were unfit for open repair, and nine had undergone prior aortic surgery. Cus-
tomized aortic stent grafts were inserted through surgically exposed femoral
(n = 16) or iliac (n = 6) arteries. Covered stents were inserted through surgi-
cally exposed brachial arteries. Spinal catheters were used for cerebrospinal
fluid pressure drainage in 22 patients and for and spinal anesthesia in 11.
Results. All 22 stent grafts and all 81 branches were deployed successfully.
Aortic coverage as a percentage of subclavian-to-bifurcation distance was
69%  20%. Mean contrast volume was 203 mL, mean blood loss was
714 mL, and mean hospital stay was 10.9 days. Two patients (9.1%) died peri-
operatively: one from guidewire injury to a renal arterial branch and the
other from a medication error. Serious or potentially serious complications
occurred in 9 of 22 patients (41%). There was no paraplegia, renal failure,
stroke, or myocardial infarction among the 20 surviving patients. Two pa-
tients (9.1%) underwent successful reintervention: one for localized intimal
disruption and the other for aortic dissection, type I endoleak, and stenosis
of the superior mesenteric artery. One patient has a type II endoleak. Fol-
low-up is >1 month in 19 patients, >6 months in 12, and >12 months in 8.
One branch (renal artery) occluded for a 98.75% branch patency rate at 1
month. The other 80 branches remain patent. There are no signs of stent graft
migration, component separation, or fracture.
Conclusions. Multibranched stent graft implantation eliminates aneurysm
flow, preserves visceral perfusion, and avoids many of the physiologic
stresses associated with other forms of repair. The results support an ex-
panded role for this technique in the treatment of TAAA.
Peak wall stress measurement in elective and acute abdominal aortic
aneurysms
M.S. Heng, M.J. Fagan, J.W. Collier, G. Desai, P.T. McCollum and I.C. Chetter
Background. Abdominal aortic aneurysm (AAA) rupture occurs when wall
stress exceedswall strength. Engineering principles suggest that aneurysmdia-
meter is only one aspect of its geometry that influences wall stress. Finite ele-
ment analysis considers the complete geometry and determines wall stresses
throughout the structure. This article investigates the interoperator and intraop-
erator reliability of finite element analysis in the calculation of peak wall stress
(PWS) in AAA and examines the variation in PWS in elective and acute AAAs.
Method. Full ethics and institutional approval was obtained. The study re-
cruited 70 patients (30 acute, 40 elective) with an infrarenal AAA. Computed
tomography (CT) images were obtained of the AAA from the renal vessels to
the aortic bifurcation. Manual edge extraction, three-dimensional reconstruc-
tion, and blinded finite element analysis were performed to ascertain location
and value of PWS. Ten CT data sets were analyzed by four different operators
to ascertain interoperator reliability and by one operator twice to ascertain in-
traoperator reliability. An intraclass correlation coefficient was obtained. The
Mann-Whitney U test and independent samples t test compared groups for
statistical significance.
Results. The intraclass correlation coefficient was 0.71 for interoperator reli-
ability and 0.84 for intraoperator reliability. There was no statistically signif-
icant difference in the mean (SD) maximal AAA diameter between elective
(6.47 [1.30] cm) and acute (7.08 [1.39] cm) patients (P = .073). The difference
in PWS between elective (0.67 [0.30] MPa) and acute (1.11 [ 0.51] MPa)
patients (P = .008) was statistically significant, however.
* Full articles available online at www.jvascsurg.orgYEJVS2948_2974_proof  6
1078e5884/000124 + 03 $32.00/0  2007 Published by Elsevier Ltd on behalfConclusion. Interoperator and intraoperator reliability in the derivation of
PWS is acceptable. PWS, but not maximal diameter, was significantly higher
in acute AAAs than in elective AAAs.
Profunda femoris artery aneurysms: Association with aneurysmal
disease and limb ischemia
C. Harbuzariu, A.A. Duncan, T.C. Bower, M. Kalra and P. Gloviczki
Objectives. Because there is a paucity of data about management and out-
come of true profunda femoris artery aneurysms (PFAAs), we reviewed
our 21-year experience with surgical repair of PFAAs.
Methods. Clinical data from the 15 patients who underwent repair between
1985 and 2006 were retrospectively reviewed.
Results. Fifteen men had 17 PFAAs (mean diameter, of 3.4 cm). Three had an
acute presentation with rupture (n = 2) or acute limb ischemia (n = 1), one
had local tenderness, and 11 were asymptomatic. Sizes of the ruptured
PFAAs were 1.5 and 7.5 cm. Eleven patients (73%) had synchronous aneu-
rysms, most frequently in the popliteal artery (n = 7). Three of the asymptom-
atic patients required an emergency operation because of acute lower
extremity ischemia caused by thrombosis of a synchronous popliteal aneu-
rysm (n = 2) or for a ruptured iliac aneurysm (n = 1). Aneurysmectomy
with graft interposition between the common femoral and PFA was used in
15 repairs. Ligation alone was used for one aneurysm, and another was
treated by partial aneurysmectomy with primary repair. There were no
deaths, graft thrombosis, or limb loss at 30 days. At a mean follow-up of
28 months (range 3 to 108 months), one patient required above knee amputa-
tion 2 years after aneurysm ligation, and another patient presented with a re-
current aneurysm. Long-term graft patency was 100%.
Conclusions. PFAAs are rare but often occur with synchronous aneurysms.
One-third of patients presented with complications of limb ischemia or rup-
ture caused by their PFAA or synchronous aneurysms. Good-risk patients
with a PFAA >2 cm should undergo elective repair. Aneurysmectomy with
femoral interposition graft is a durable repair.
Aortic reconstruction with femoral-popliteal vein: Graft stenosis
incidence, risk and reintervention
A.W. Beck, E.H. Murphy, J.A. Hocking, C.H. Timaran, F.R. Arko and
G.P. Clagett
Background. Management using femoral-popliteal vein (FPV) of aortic graft in-
fections, failing aortofemoral bypass, and aortoiliac occlusive disease in young
patients with a small aorta is now an accepted therapeutic method and is per-
formed frequently at our institution. A high reintervention rate for FPV graft
stenosis has recently been reported. The purpose of this studywas to determine
the incidence of FPV graft failure due to stenosis after neoaortoiliac system
(NAIS) reconstruction, and to identify risk factors for this complication.
Methods. A review was performed of 240 patients who underwent NAIS re-
construction at our institution between January 1991 and December 2005. All
patients were entered into a prospective database and were evaluated for the
incidence of vein graft stenosis requiring reintervention, risk factors for ste-
nosis, and the rate and type of reintervention required to assist patency.
Patients with occlusion are evaluated and reported, but excluded from de-
tailed analysis. Risk factors assessed included gender, operative features,
FPV size (diameter), smoking history, and medical comorbidities.
Results. Of the 240 NAIS procedures performed during this time period, 11
(4.6%) patients have required 12 graft revisions (one patient required a second
intervention) for stenosis using open and endovascular techniques. Over the
same time period, graft occlusion occurred in nine patients (3.8%). This pro-
vided a primary patency at 2 and 5 years of 87% and 82%, and an assisted
primary patency rate of 96% and 94%. Mean time to revision was 23.5 months
(range 5.5 to 83.5 months). Median FPV graft size in the nonrevised patients
was 7.8 mm (range 4.0 to 11.4 mm), and 6.4 mm (range 4.7 to 8.7 mm) in theDecember 2007  124/126
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125Abstractsrevised group (P = .006). Survival analysis revealed small vein graft size (<7.2
mm), coronary artery disease (CAD), and extensive smoking history as inde-
pendent predictors of time to stenosis (P = .002, .02, .01, respectively), with
multivariable analysis confirming these results (P = .002, .06, .012). Patients
with CAD combined with small graft size were found to be at especially
high risk for stenosis, with 8/36 (22.2%) requiring revision vs 3/184 (1.6%)
of patients without both factors (P < .0001).
Conclusions. FPV graft stenosis requiring revision after NAIS reconstruction
is uncommon. Risk factors for stenosis include small graft size, history of
CAD, and smoking. All patients merit aggressive counseling for smoking ces-
sation, and patients exhibiting multiple risk factors should undergo close
postoperative surveillance for graft stenosis.
Duplex ultrasound velocity criteria for the stented carotid artery
B.K. Lal, R.W. Hobson II, B. Tofighi, I. Kapadia, S. Cuadra and Z. Jamil
Objectives. Ultrasound velocity criteria for the diagnosis of in-stent resteno-
sis in patients undergoing carotid artery stenting (CAS) are not well estab-
lished. In the present study, we test whether ultrasound velocity
measurements correlate with increasing degrees of in-stent restenosis in pa-
tients undergoing CAS and develop customized velocity criteria to identify
residual stenosis 20%, in-stent restenosis 50%, and high-grade in-stent
restenosis 80%.
Methods. Carotid angiograms performed at the completion of CAS were
compared with duplex ultrasound (DUS) imaging performed immediately
after the procedure. Patients were followed up with annual DUS imaging
and underwent both ultrasound scans and computed tomography angio-
graphy (CTA) at their most recent follow-up visit. Patients with suspected
high-grade in-stent restenosis on DUS imaging underwent diagnostic carotid
angiograms. DUS findings were therefore available for comparison with lu-
minal stenosis measured by carotid angiograms or CTA in all these patients.
The DUS protocol included peak-systolic (PSV) and end-diastolic velocity
(EDV) measurements in the native common carotid artery (CCA), proximal
stent, mid stent, distal stent, and distal internal carotid artery (ICA).
Results. Of 255 CAS procedures that were reviewed, 39 had contralateral ICA
stenosis and were excluded from the study. During a mean follow-up of 4.6
years (range 1 to 10 years), 23 patients died and 64 were lost. Available for
analysis were 189 pairs of ultrasound and procedural carotid angiogram
measurements; 99 pairs of ultrasound and CTAmeasurements during routine
follow-up; and 29 pairs of ultrasound and carotid angiograms measurements
during follow-up for suspected high-grade in-stent restenosis 80% (n = 310
pairs of observations, ultrasound vs carotid angiograms/CTA). The accuracy
of CTA vs carotid angiograms was confirmed (r2 = 0.88) in a subset of 19
patients. Post-CAS PSV (r2 = .85) and ICA/CCA ratios (r2 = 0.76) correlated
most with the degree of stenosis. Receiver operating characteristic analysis
demonstrated the following optimal threshold criteria: residual stenosis
20% (PSV 150 cm/s and ICA/CCA ratio 2.15), in-stent restenosis 50%
(PSV 220 cm/s and ICA/CCA ratio 2.7), and in-stent restenosis 80%
(PSV 340 cm/s and ICA/CCA ratio 4.15).
Conclusions. Progressively increasing PSV and ICA/CCA ratios correlate
with evolving restenosis within the stented carotid artery. Ultrasound veloc-
ity criteria developed for native arteries overestimate the degree of in-stent
restenosis encountered. These changes persist during long-term follow-up
and across all grades of in-stent restenosis after CAS. The proposed new ve-
locity criteria accurately define residual stenosis 20%, in-stent restenosis
50%, and high-grade in-stent restenosis 80% in the stented carotid artery.
Angiographic lesion characteristics can predict adverse outcomes
after carotid artery stenting
S. Sayeed, S.F. Stanziale, M.H. Wholey and M.S. Makaroun
Background. Carotid artery angioplasty and stenting (CAS) is an evolving
and increasingly common endovascular treatment for carotid artery stenosis.
Risk factors associated with an increased incidence of adverse periprocedural
neurologic outcomes are being recognized. The goal of this study was to de-
termine if certain angiographic lesion characteristics were predictive of
higher risks of adverse outcomes.
Methods. A total of 421 patients who underwent 429 carotid artery stenting
procedures between June 1996 and June 2005 for symptomatic orasymptomatic carotid stenosis, and in whom preoperative carotid angio-
grams and follow-up records were available for review, were selected from
a prospectively maintained database. Demographic data and procedural vari-
ables were recorded, including the presence or absence of the use of a cerebral
protection device. Angiograms were reviewed for the following carotid lesion
characteristics: length of lesion, percentage of stenosis, ostial involvement, le-
sion ulceration, calcification, and presence of contralateral carotid occlusion.
Periprocedural stroke and 30-day adverse event rates (stroke, myocardial in-
farction, and death) were recorded for each patient.
Results. The periprocedural all-stroke rate was 3.7%. Octogenarians had
a higher incidence of 30-day adverse events at 10.0% vs 3.8% (P = .029).
The incidence of periprocedural stroke was increased in lesions 15 mm
long, at 17.0% (8 of 47) vs 2.1% (8 of 382; P < .001), and in ostial centered le-
sions, 7.1% (11 of 154) vs 1.8% (5 of 275; P = .007). Multivariate regression also
identified these two variables as independently associated with 30-day stroke
rate: lesion length 15 mm (odds ratio [OR], 6.38; 95% confidence interval
[CI], 35 to 17.29) or ostial involvement (OR, 3.12; 95% CI, 3.12 to 8.36). Other
variables, including lesion calcification, ulceration, degree of stenosis, or pres-
ence of contralateral occlusion, were not associated with adverse outcomes.
When studied separately, the use of cerebral protection devices in 241 pa-
tients (56%) did not change our observed correlations between angiographic
characteristics and adverse procedural events.
Conclusions. Certain lesion characteristics on angiography, such as length
and ostial location, can predict adverse outcomes. The indication for CAS
should be carefully evaluated in these cases.
Transcervical carotid stenting with flow reversal is safe in
octogenarians: A preliminary safety study
B. Alvarez, M. Ribo, J. Maeso, M. Quintana, J. Alvarez-Sabin and M. Matas
Background. The use of carotid stenting in octogenarian patients is controver-
sial; some authors consider this population at high risk for the procedure. An-
atomic vascular complexity may be an important reason for the high reported
rates of periprocedural thromboembolic complications. Transcervical carotid
angioplasty and stenting (TCS) with flow reversal avoids aortic arch instru-
mentation. In this study, we analyzed our experience with TCS in octogenar-
ian patients and compared the results with those of carotid endarterectomy
(CEA) in the same age group in terms of safety.
Methods. The study included 81 patients, 80 years, a retrospective cohort
of 45 consecutive patients treated with CEA (January 2002 to January 2005),
and a prospective cohort of 36 consecutive patients treated with TCS with
protective flow reversal (January 2005 to January 2007). Patients were con-
sidered symptomatic according to the North American Symptomatic Ca-
rotid Endarterectomy Trial (NASCET) criteria. Stenting indication was
established on the SAPPHIRE criteria. General anesthesia was used in pa-
tients undergoing CEA, and local anesthesia in those receiving TCS. Pri-
mary endpoints were: stroke, death, or acute myocardial infarction within
30 days. Secondary endpoints were peripheral nerve paralysis and cervical
hematoma. Statistical significance for between-group differences was as-
sessed by Pearson c2 or Fisher exact test, and Student t test. A P value of
<.05 was considered statistically significant. Follow-up was limited to 30
days.
Results. Baseline epidemiological characteristics and revascularization indi-
cations were similar between both groups. Mean age was significantly higher
in the TCS group (83.5  3.35) than the CEA group (81.7  1.55) (P = .004).
Percentage of symptomatic lesions was similar: 30.6% in TCS vs 44.4% in
CEA (P = .2). Comorbid conditions (respiratory or cardiac) were more fre-
quent in TCS group (61.6% vs 26.6%; P = .002). There were no significant dif-
ferences between groups for the primary endpoints: 4.4% (one stroke, one
acute myocardial infarction) for CEA vs 0% for TCS (P = .5). Among CEA pa-
tients, there were two peripheral nerve palsies (4.4%) and one cervical hema-
toma (2.2%); there were no such complications with TCS (P = .5 and P = 1,
respectively). In one asymptomatic TCS patient, Doppler study at 24 hours
following the procedure showed a common carotid artery dissection, which
was treated by a common carotid to internal carotid bypass.
Conclusions. In this preliminary experience, transcervical carotid angioplasty
and stenting with flow reversal for cerebral protection was as safe at short
term as carotid endarterectomy in octogenarian patients, who additionally
had considerable comorbidity; thus, it may be possible to extend the
126 Abstractsindications for carotid revascularization in this population. Studies in larger
patient series are required to confirm the trends observed in this study.
Reduced primary patency rate in diabetic patients after percutaneous
intervention results from more frequent presentation with
limb-threatening ischemia
B.G. DeRubertis, M. Pierce, E.J. Ryer, S. Trocciola, K.C. Kent and P.L. Faries
Objective. Although patients with diabetes are at increased risk of amputa-
tion from peripheral vascular disease, excellent limb-salvage rates have
been achieved with aggressive surgical revascularization. It is less clear
whether patients with diabetes will fare as well as nondiabetics after under-
going percutaneous lower extremity revascularization, a modality which is
becoming increasingly utilized for this disease process. This study aimed to
assess differential outcomes in between diabetics and nondiabetics in lower
extremity percutaneous interventions.
Methods. We retrospectively studied 291 patients with respect to patient vari-
ables, complications, and outcomes for percutaneous interventions per-
formed for peripheral occlusive disease between 2002 and 2005. Tibial
vessel run-off was assessed by angiography. Patency (assessed arterial du-
plex) was expressed by Kaplan-Meier method and log-rank analysis. Mean
follow-up was 11.6 months (range 1 to 56 months).
Results. A total of 385 interventions for peripheral occlusive disease with
claudication (52.2%), rest pain (16.4%), or tissue loss (31.4%) were analyzed,
including 336 primary interventions and 49 reinterventions (mean patient
age 73.9 years, 50.8% male). Comorbidities included diabetes mellitus
(57.2%), chronic renal insufficiency (CRI) (18.4%), hemodialysis (3.8%),
hypertension (81.9%), hypercholesterolemia (57%), coronary artery diseaseEur J Vasc Endovasc Surg Vol 35, January 2008(58%), tobacco use (63.2%). Diabetics were significantly more likely to be fe-
male (55.3% vs 40.8%), and suffer from CRI (23.5% vs 12.0%), a history of
myocardial infarction (36.5% vs 18.0%), and <three-vessel tibial outflow
(83.5% vs 71.8%), compared with nondiabetics, although all other comorbid-
ities and lesion characteristics were equivalent between these groups. Over-
all primary patency ( SE) at 6, 12, and 18 months was 85  2%, 63  3%
and 56  4%, respectively. Patients with diabetes suffered reduced primary
patency at 1 year compared with nondiabetics. For nondiabetics, primary
patency was 88  2%, 71  4%, and 58  4% at 6, 12, and 18 months, while
for diabetics it was 82  2%, 53  4%, and 49  4%, respectively (P = .05).
Overall secondary patency at 6, 12, and 18 months was 88  2%, 76  3%,
and 69  3%, and did not vary by diabetes status. One-year limb salvage
rate was 88.3% for patients with limb-threatening ischemia, which was
also similar between diabetics and nondiabetics. While univariate analysis
revealed that female gender, <three-vessel tibial outflow, and a history of
tobacco use were all predictive of reduced primary patency (P < .05),
none of these factors significantly impacted secondary patency or
limb-salvage rate. Furthermore, only limb-threatening ischemia remained
a significant predictor of outcome on multivariate analysis, suggesting
that the poorer primary patency in diabetics is related primarily to their
propensity to present with limb-threatening disease compared with
nondiabetics.
Conclusion. Patients with diabetes demonstrate reduced primary patency
rates after percutaneous treatment of lower extremity occlusive disease,
most likely due to their advanced stage of disease at presentation. How-
ever, despite a higher reintervention rate, diabetics and others with risk
factors predictive of reduced primary patency can attain equivalent
short-term secondary patency and limb-salvage rates. Therefore, these pa-
tient characteristics should not be considered contraindications to endovas-
cular therapy.
